CUSIP 58933Y105 · who reports it, how much, and how much it matters to them
59 of the 720 hedge fund managers we track reported shares of Merck & Co., Inc. (NYSE: MRK) on Form 13F for 30 June 2026. Between them they reported USD 2.7bn. The largest position belongs to Grantham Mayo Van Otterloo & Co, at USD 872m. The manager with the most riding on it is Stamos Capital Partners, where it is 3.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Grantham Mayo Van Otterloo & Co1 fund on PPLI.com | USD 872m | 2.0% |
| 2 | D. E. Shaw & Co.15 funds on PPLI.com | USD 352m | 0.2% |
| 3 | Adage Capital Management1 fund on PPLI.com | USD 261m | 0.4% |
| 4 | Citadel Advisors32 funds on PPLI.com | USD 248m | 0.0% |
| 5 | CIBC Asset Management69 funds on PPLI.com | USD 149m | 0.3% |
| 6 | Squarepoint Ops7 funds on PPLI.com | USD 117m | 0.1% |
| 7 | Orbimed Advisors1 fund on PPLI.com | USD 85m | 1.6% |
| 8 | Holocene Advisors2 funds on PPLI.com | USD 81m | 0.2% |
| 9 | IFM Investors Pty7 funds on PPLI.com | USD 73m | 0.5% |
| 10 | Samlyn Capital8 funds on PPLI.com | USD 73m | 1.2% |
| 11 | Millennium Management6 funds on PPLI.com | USD 72m | 0.0% |
| 12 | POINT72 Asset Management17 funds on PPLI.com | USD 49m | 0.1% |
| 13 | Voleon Capital Management13 funds on PPLI.com | USD 38m | 0.7% |
| 14 | RWC Asset Management LLP1 fund on PPLI.com | USD 27m | 1.0% |
| 15 | Farallon Capital Management56 funds on PPLI.com | USD 26m | 0.1% |
| 16 | Stamos Capital Partners21 funds on PPLI.com | USD 23m | 3.5% |
| 17 | Cinctive Capital Management5 funds on PPLI.com | USD 19m | 0.7% |
| 18 | LMCG Investments2 funds on PPLI.com | USD 18m | 1.0% |
| 19 | PFM Health Sciences3 funds on PPLI.com | USD 16m | 1.4% |
| 20 | Kinneret Advisory7 funds on PPLI.com | USD 12m | 1.0% |
| 21 | Artisan Partners1 fund on PPLI.com | USD 11m | 0.0% |
| 22 | Platinum Investment Management11 funds on PPLI.com | USD 8.1m | 2.0% |
| 23 | Gamco Asset Management1 fund on PPLI.com | USD 8.1m | 0.1% |
| 24 | Sphera Funds Management1 fund on PPLI.com | USD 7.5m | 1.0% |
| 25 | Balyasny Asset Management25 funds on PPLI.com | USD 7.2m | 0.0% |
| 26 | Verition Fund Management3 funds on PPLI.com | USD 6.9m | 0.0% |
| 27 | Weiss Asset Management5 funds on PPLI.com | USD 6.7m | 0.1% |
| 28 | Brevan Howard Capital Management39 funds on PPLI.com | USD 6.4m | 0.0% |
| 29 | Two Sigma Investments35 funds on PPLI.com | USD 6.2m | 0.0% |
| 30 | Artia Global Partners1 fund on PPLI.com | USD 6m | 1.1% |
| 31 | Arnhold3 funds on PPLI.com | USD 6m | 0.4% |
| 32 | Trust Asset Management4 funds on PPLI.com | USD 5.7m | 0.2% |
| 33 | LMR Partners2 funds on PPLI.com | USD 5.7m | 0.0% |
| 34 | Bridgewater Associates45 funds on PPLI.com | USD 3.9m | 0.0% |
| 35 | Freestone Grove Partners1 fund on PPLI.com | USD 3.5m | 0.0% |
| 36 | Jain Global1 fund on PPLI.com | USD 3.2m | 0.0% |
| 37 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 2m | 0.0% |
| 38 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 1.6m | 0.2% |
| 39 | Capital Fund Management S.A.12 funds on PPLI.com | USD 1.5m | 0.0% |
| 40 | Gluskin Sheff + Associates14 funds on PPLI.com | USD 1.2m | 0.2% |
| 41 | Dark Forest Capital Management2 funds on PPLI.com | USD 1.1m | 0.1% |
| 42 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 1m | 0.1% |
| 43 | Cercano Management5 funds on PPLI.com | USD 920,000 | 0.1% |
| 44 | Sender Company & Partners1 fund on PPLI.com | USD 694,000 | 0.2% |
| 45 | Capstone Investment Advisors25 funds on PPLI.com | USD 515,000 | 0.0% |
| 46 | Capricorn Fund Managers8 funds on PPLI.com | USD 514,000 | 0.0% |
| 47 | Neo Ivy Capital Management1 fund on PPLI.com | USD 401,000 | 0.1% |
| 48 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 347,000 | 0.1% |
| 49 | Barings1 fund on PPLI.com | USD 329,000 | 0.0% |
| 50 | Verdad Advisers6 funds on PPLI.com | USD 319,000 | 0.3% |
| 51 | Granville Capital7 funds on PPLI.com | USD 316,000 | 0.1% |
| 52 | Hudson Bay Capital Management8 funds on PPLI.com | USD 284,000 | 0.0% |
| 53 | Walleye Capital8 funds on PPLI.com | USD 274,000 | 0.0% |
| 54 | Seldon Capital1 fund on PPLI.com | USD 241,000 | 0.1% |
| 55 | Bayforest Capital1 fund on PPLI.com | USD 169,000 | 0.2% |
| 56 | Battery Global Advisors16 funds on PPLI.com | USD 92,873 | 0.0% |
| 57 | The Bollard Group7 funds on PPLI.com | USD 18,881 | 0.6% |
| 58 | Summit Global Investments1 fund on PPLI.com | USD 6,687 | 0.4% |
| 59 | The Quarry1 fund on PPLI.com | USD 514 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Stamos Capital Partners | USD 23m | 3.5% |
| 2 | Platinum Investment Management | USD 8.1m | 2.0% |
| 3 | Grantham Mayo Van Otterloo & Co | USD 872m | 2.0% |
| 4 | Orbimed Advisors | USD 85m | 1.6% |
| 5 | PFM Health Sciences | USD 16m | 1.4% |
| 6 | Samlyn Capital | USD 73m | 1.2% |
| 7 | Artia Global Partners | USD 6m | 1.1% |
| 8 | RWC Asset Management LLP | USD 27m | 1.0% |
| 9 | Sphera Funds Management | USD 7.5m | 1.0% |
| 10 | LMCG Investments | USD 18m | 1.0% |
Merck & Co., Inc. trades under the symbol MRK on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 58933Y105.
59 of the 720 hedge fund managers PPLI.com tracks reported Merck & Co., Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Grantham Mayo Van Otterloo & Co (USD 872m), D. E. Shaw & Co. (USD 352m), Adage Capital Management (USD 261m), Citadel Advisors (USD 248m) and CIBC Asset Management (USD 149m).
59 managers in our coverage reported it, and between them they run 632 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Stamos Capital Partners, where the position was 3.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Merck & Co., Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.